Late PET/CT Findings of COVID-19 Pneumonia With 2 Different Radiopharmaceuticals in a Patient PSMA Avidity Higher Than FDGs

dc.contributor.authorSahin, Ozlem
dc.contributor.authorKaya, Bugra
dc.contributor.authorAydin, Zeynep
dc.contributor.authorKaraagac, Mustafa
dc.contributor.authorKanyilmaz, Gul
dc.date.accessioned2024-02-23T14:21:19Z
dc.date.available2024-02-23T14:21:19Z
dc.date.issued2021
dc.departmentNEÜen_US
dc.description.abstractWe present the Ga-68-PSMA and F-18-FDG PET/CT findings comparatively of a 67-year-old prostate cancer and malignant melanoma patient who had COVID-19 pneumonia 3 months ago. In Ga-68-PSMA PET/CT, ground-glass opacities showing markedly increased PSMA uptake were observed in the patient's lungs. It was learned that the patient had COVID-19 pneumonia 3 months ago and was treated in the intensive care unit for 13 days. In F-18-FDG PET/CT, FDG uptake was minimal in the same areas. In the midterm period after COVID-19 pneumonia, lung PSMA uptake is more intense than FDG, which may help better understand the disease's healing phase.en_US
dc.identifier.doi10.1097/RLU.0000000000003720
dc.identifier.endpageE522en_US
dc.identifier.issn0363-9762
dc.identifier.issn1536-0229
dc.identifier.issue10en_US
dc.identifier.pmid34477606en_US
dc.identifier.scopus2-s2.0-85115901102en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpageE521en_US
dc.identifier.urihttps://doi.org/10.1097/RLU.0000000000003720
dc.identifier.urihttps://hdl.handle.net/20.500.12452/13542
dc.identifier.volume46en_US
dc.identifier.wosWOS:000697238000014en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofClinical Nuclear Medicineen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectFdgen_US
dc.subjectPsmaen_US
dc.subjectPet/Cten_US
dc.subjectCovid-19en_US
dc.subjectGround-Glass Opacitiesen_US
dc.titleLate PET/CT Findings of COVID-19 Pneumonia With 2 Different Radiopharmaceuticals in a Patient PSMA Avidity Higher Than FDGsen_US
dc.typeEditorial Materialen_US

Dosyalar